Your browser doesn't support javascript.
loading
Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma.
Burke, John M; van der Jagt, Richard H C; Kahl, Brad S; Wood, Peter; Hawkins, Tim E; MacDonald, David; Hertzberg, Mark; Simpson, David; Craig, Michael; Kolibaba, Kathryn; Issa, Samar; Munteanu, Mihaela; Victor, Timothy W; Flinn, Ian W.
Afiliação
  • Burke JM; US Oncology Research, McKesson Specialty Health, The Woodlands, TX; Medical Oncology, Rocky Mountain Cancer Centers, Aurora, CO. Electronic address: john.burke@usoncology.com.
  • van der Jagt RH; Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Kahl BS; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin, Carbone Cancer Center, Madison, WI.
  • Wood P; Department of Haematology, Princess Alexandra Hospital, Queensland, Australia.
  • Hawkins TE; Department of Haematology, Auckland Hospital, Auckland, New Zealand.
  • MacDonald D; Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
  • Hertzberg M; Department of Haematology, Westmead Hospital, New South Wales, Australia.
  • Simpson D; Department of Haematology, North Shore Hospital, Takapuna, New Zealand.
  • Craig M; Department of Medicine, Section of Hematology/Oncology, West Virginia University, Morgantown, WV.
  • Kolibaba K; US Oncology Research, McKesson Specialty Health, The Woodlands, TX; Medical Oncology/Hematology Specialty, Compass Oncology, Vancouver, WA.
  • Issa S; Department of Haematology, Middlemore Hospital, Auckland, New Zealand.
  • Munteanu M; New Therapeutic Entity, Clinical Research and Development, Teva Branded Pharmaceutical Products R&D, Inc, Frazer, PA.
  • Victor TW; Science and Strategy, Kantar Health, Princeton, NJ; Department Biostatistics and Epidemiology, University of Pennsylvania, Graduate School of Education, Philadelphia, PA.
  • Flinn IW; Blood Cancer Research Program, Sarah Cannon Research Institute, Nashville, TN.
Clin Lymphoma Myeloma Leuk ; 16(4): 182-190.e1, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26875824
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto / Cloridrato de Bendamustina / Rituximab Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto / Cloridrato de Bendamustina / Rituximab Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article